WO2025255373 - FATTY ACID AND CYCLIZED DERIVATIVES OF THE IMMUNOMODULATORY PEPTIDE RP-182 WITH IMPROVED ANTI-TUMOR ACTIVITY, COMPOSITIONS, AND METHODS OF USE THEREOF
National phase entry is expected:
Publication Number
WO/2025/255373
Publication Date
11.12.2025
International Application No.
PCT/US2025/032497
International Filing Date
05.06.2025
Title **
[English]
FATTY ACID AND CYCLIZED DERIVATIVES OF THE IMMUNOMODULATORY PEPTIDE RP-182 WITH IMPROVED ANTI-TUMOR ACTIVITY, COMPOSITIONS, AND METHODS OF USE THEREOF
[French]
ACIDE GRAS ET DÉRIVÉS CYCLISÉS DU PEPTIDE IMMUNOMODULATEUR RP-182 À ACTIVITÉ ANTITUMORALE AMÉLIORÉE, COMPOSITIONS ET LEURS PROCÉDÉS D'UTILISATION
Applicants **
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Inventors
RUDLOFF, Udo
SINGH, Sitanshu Sekhar
SABLE, Rushikesh Vilas
KUMARI, Anju
MARUGAN, Juan Jose
CALVO, Raul Ronaldo
HU, Xin
CASTLE, Sarah Gray
HENDERSON, Mark James
Priority Data
63/656,535
05.06.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2588 | |
| EPO | Filing, Examination, Granting | 10762 | |
| Japan | Filing, Examination, Granting | 1784 | |
| South Korea | Filing, Examination, Granting | 1317 | |
| USA | Filing, Examination, Granting | 5190 |
Total:
21,641
Contact Us
Abstract[English]
Aspects of the present disclosure relate to immunomodulatory peptides that modulate CD206 and modulate macrophage activity, compositions containing one or more of the immunomodulatory peptides, and methods of their use.[French]
Des aspects de la présente divulgation concernent des peptides immunomodulateurs qui modulent CD206 et modulent l'activité des macrophages, des compositions contenant un ou plusieurs des peptides immunomodulateurs, et des procédés d'utilisation de ceux-ci.